With reports of HDAC3 binding to three different ataxin proteins [18,19,47], and HDAC3-specific inhibition ameliorating disease in animal models [31,32,34], our study adds to growing evidence for HDAC3 modulation as a target for multiple neurodegenerative diseases. This evidence concerns the gene HDAC3 and neurodegenerative disease.